Cepharanthine as an effective small cell lung cancer inhibitor: integrated insights from network pharmacology, RNA sequencing, and experimental validation
BackgroundSmall cell lung cancer (SCLC) is an aggressive malignancy with limited treatment options and poor prognosis, underscoring the need for new therapeutic agents.MethodsA library of 640 natural products was screened for anti-proliferative activity in SCLC cells. The effects of Cepharanthine (C...
Saved in:
| Main Authors: | Fengyun Zhao, Zhaowei Ding, Mengting Chen, Mingfang Ji, Fugui Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1517386/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of cepharanthine as an effective inhibitor of African swine fever virus replication
by: Chuanxiang Qi, et al.
Published: (2024-12-01) -
Cepharanthine synergizes with photodynamic therapy for boosting ROS-driven DNA damage and suppressing MTH1 as a potential anti-cancer strategy
by: Zi-Yi Yang, et al.
Published: (2024-02-01) -
Safety and efficacy of oral administrated cepharanthine in non-hospitalized, asymptomatic or mild COVID-19 patients: a Double-blind, randomized, placebo-controlled trial
by: Jianyi Wei, et al.
Published: (2025-01-01) -
Protective Role of Cepharanthine Against Equid Herpesvirus Type 8 Through AMPK and Nrf2/HO-1 Pathway Activation
by: Shuwen Li, et al.
Published: (2024-11-01) -
Anti-lung Cancer Mechanism of Quercetin Based on Network Pharmacology and Experimental Validation
by: Yi WANG, et al.
Published: (2025-01-01)